Log In
Print this Print this

Integrin alpha 5 beta 1 antagonist

  Manage Alerts
Collapse Summary General Information
Company InnoPharmaScreen Inc.
DescriptionAntagonist peptide against integrin alpha 5 beta 1
Molecular Target Integrin alpha(5)beta(1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today